TRANDD
Live / Allowed — Published for opposition (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99420151
- Mark type
- Stylized text
- Filed
- 30 Sept 2025
- Published for opposition
- 18 Aug 2026
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceutical drugs; Medical and scientific research in the field of drug development, treatment strategies, and clinical trial planning; Clinical research in the field of cardiometabolic diseases and inflammatory disorders; Research and development services in the field of pharmaceutical drug discovery and clinical trial optimization; Providing medical and scientific research information in the field of clinical trials, namely, clinical trial strategies, clinical study methodologies to improve trial efficiency, patient outcomes, and data quality; Providing medical research information in the field of pharmaceuticals, namely, providing information via a research framework regarding drug development, treatment strategies, and clinical research; consulting services in the field of pharmaceutical research, namely, drug development and clinical trial planning
- Class 044 — Medical, beauty and agricultural services: Medical advisory services on clinical trial protocol optimization
Owner
- Eccogene Inc., Cambridge, MA, US
- Eccogene Inc., Cambridge, MA, US
Prosecution history
- 18 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2026 — PUBLISHED FOR OPPOSITION
- 12 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 22 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 20 May 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 20 May 2026 — FINAL REFUSAL E-MAILED
- 20 May 2026 — FINAL REFUSAL WRITTEN
- 18 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED